奥拉西坦改善高血压脑出血患者认知功能的临床研究(2)
 |
| 第1页 |
参见附件(180KB，2页)。
[参考文献]
[1]陈士东.高血压性壳核出血CT分型与短期康复预后的关系[J].现代预防医学,2005,32 (9):1200-1204.
[2]Parnetti L,Mecocci P,Gaiti A, et al. Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type[J]. Eur J Drug Metab Pharmacokinet,1990,15(1):75-78.
[3]Ponzio F, Pozzi O, Banfi S, et al. Brain entry and direct central pharmacological effects of the nootropic drug oxiracetam. Oxiracetam: brain entry and pharmacological effects[J].Pharmacopsychiatry,1989,22(Suppl 2):111-115.
[4]Lecaillon JB, Dubois JP, Coppens H, et al. Pharmacokinetics of oxiracetam in elderly patients after 800 mg oral doses, comparison with non-geriatric healthy subjects[J].Eur J Drug Metab Pharmacokinet,1990,15(3):223-230.
[5]Banfi S, Dorigetti L. Experimental behavioral studies with oxiracetam on different types of chronic cerebral impairment[J].Clin Neuropharmacol,1986,9 (Suppl 3):19-26.
[6]王体强,徐楠,王溶生.新型益智药奥拉西坦的药理与临床应用进展[J].四川生理科学杂志,2002,24:145-148.
[7]Cavoy A，Van Golf-Racht B, Delacour J. Relationships between arousal and coginition-enhancing effects of oxiracetam[J].Pharmacol Biochem Behav，1994, 47(2):283-287.
[8]Maina G, Fiori L , Torta R ,et al. Oxiracetam in the treatment of primary degenerative and multi-infarct dementia: a double-blind, placebo-controlled study[J].Neuropsychobiology，1989,21(3):141-145.
(收稿日期：2007-09-20)
“本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文”
您现在查看是摘要介绍页，详见PDF附件(180KB，2页)。